REC — Recordati Industria Chimica e Farmaceutica Share News
0.000.00%
Last trade - 00:00- €10.91bn
- €12.82bn
- €2.62bn
Deals of the day-Mergers and acquisitions
Brief: Recordati Says 66.67% Threshold Condition In Recordati Fulfilled
Brief: Recordati - CVC Capital Partners IX Aggregator Holds 19,189,219 Recordati Shares, 9.18% Of Share Capital
CVC, GBL hold 74.3% of Italian drugmaker Recordati at end of takeover offer period
Italy - Factors to watch on October 23
Europe Research Roundup: CTS Eventim, Pantheon International, Standard Chartered
Brief: Recordati Says Generic Abbreviated New Drug Filer Asks US FDA Approval To Market Generic Version Of Own Drug Isturisa
Brief: Respighi BidCo Signs Sale And Purchase Deal Concerning Around 0.66% Of Recordati's Share Capital
Brief: Respighi Bidco Offer For Recordati ObtainS Antitrust, FDI, FSR Authorizations
Brief: Recordati Says Board Welcomes Increased Consideration For Tender Offer By Respighi Bidco
CVC's cheeky Italian drug buyout will likely work
Deals of the day-Mergers and acquisitions
CVC, GBL sweeten bid for Italian drugmaker Recordati
Brief: Respighi BidCo Says It Increases Offer Price To €53 Per Recordati Share
Palliser Capital urges Recordati's board to withdraw support for CVC-GBL offer
Brief: CVC Faces Shareholder Revolt Over €10.7Bn Recordati Take-Private - FT
Italy - Factors to watch on July 29
Italy's Recordati H1 revenue rises 6.6% on rare diseases segment growth
Brief: Recordati H1 Revenue EUR 1,410.8 Million